Long laet blong ol pablikesen blong ol pruf we i jes kamaot long saed blong sefti mo wok blong haedroxychloroquine olsem wan tritmen blong COVID-19 sikman, Ekseketiv Grup blong Solidariti Trael i bin disaed blong implementem wan temporari pause blong haedroxychloroquine han insaed long trael olsem wan prekosen taem oli stap luklukbak long ol data blong sefti blong olgeta.
Olsem eksampol, wan obsevesen stadi we oli pablisim long Lancet on 22 May i faenem se, long medel blong ol 100 000 sikman we oli kam long plante kantri we oli randomisem blong kasem hydroxychloroquine, taem oli yusum olgeta nomo o wetem wan makrolaed, i gat wan hae mak blong ded mo wan inkris frikwensi blong hatbit blong hat we i no stret blong .
Wanpela laspela disisen long bagarap, benefit o nogat benefit bilong haidroksichlorokoquine bai kamap taim ol evidens i bin lukluk gen long Data Sefti Monitaring Bod{{0} Dispela riviu bai i gat ol data bilong Solidarity Traial na ol narapela traim i go het, na tu, wanem evidens ol i pablisim inap nau{1}} Em i stap long namel bilong Jun-June{3}}
Ol dispela sikman bipo ol i bin randomisim i go long haidroksichlorokokin tritmen i mas go het long kisim haidroksichlorokin inap ol i pinisim rot bilong ol long kisim tritmen{{0} Yusim bilong haidroksichlorokwine na klorokin ol i kisim olsem ol i sef long yusim long ol sikman i gat ol sik bilong bodi o malaria.
WHO i wok long skelim nau yet long yusim haidroksichlorokin long COVID-19 sikmanmeri insait long Solidarity Traial. Ol i bin pasim haidroksichlorokwine han olsem wanpela lukaut taim ol i wok long glasim ol data bilong sefti taim ol i lukluk gen long ol data bilong sefti.
Every country, particularly those with regulatory authorities, is in a position to advise its citizens regarding the use of any drug. Although hydroxychloroquine and chloroquine are already licensed products for treating other diseases, at this stage, these drugs have not been found to be effective in the treatment of COVID-19. In fact, warnings have been issued by many national authorities on the side effects of the drugs and their use has been limited in many countries to clinical trials under strict lukaut long ol seting bilong haus sik.
WHO i bin givim tok lukaut long ol dokta long tok lukaut o givim ol tritmen i no gat as bilong en long ol sikman i no gat as bilong ol long ol sikman i gat sik COVID-19 ol i no ken givim marasin long ol yet wantaim ol. Konsensus namel long ol saveman bilong wol em olsem, ol i mas mekim moa wok bilong painimaut sapos ol marasin bilong daunim sik bilong COVID i ken helpim ol, ol i ken daunim hevi bilong COVID-19. Sapos ol dispela marasin i soim olsem ol i gat sik COVID{3}} Sapos ol dispela marasin i soim olsem ol i gat sik COVID{3}} Sapos ol dispela marasin i kamap olsem ol i no inap kisim sik COVID{3}} Sapos ol dispela marasin i soim olsem ol i gat sik COVID{3}} sapos ol dispela tritmen i kamap olsem ol i gat sik COVID{3}} Sapos ol dispela."
Solidariti Trail em i wanpela intanesenel klinik traim bilong helpim long painim wanpela gutpela tritmen bilong COVID-19, WHO na ol patna. Ol i hop olsem wanpela o moa long ol tritmen aninit long traim bai kamapim long kamapim gut ol klinik autkam long COVID-19 ol narapela traim i stap long wol na tu, ol i wok long go long wol na tu, ol i go insait long Solidari Trial{3}} Ol narapela traim i stap long wol na tu ol i kisim ol samting i kamap long wol na tu, ol i ken helpim ol manmeri long kisim Solidari Traial{3}} Ol narapela traim.
Bes long ol data i kam long laboratori na klinik stadi, Remdesivir, Lopinavir/Ritonavir, Lopinavir/Ritonavir wantaim Intaferon beta-1a, na haidroksichlorokin i bin kisim pastaim olsem tritmen opsen{1}} Bihainim ol nupela evidens long sefti na wok bilong haidroksiklorokiloken, enrol bilong dispela marasin, em i bin enrol long sefti na wok bilong haidroksiklorokilokloken, na i bin stap olsem marasin bilong helpim ol sikman long haus sik, em Ol i hangamapim em long 24 Me 2020.
Ova long 100 kantri i bin soim intres long tekpat long kot na WHO i wok long sapotim moa long 60 bilong ol, na tu wantaim ol dispela samting:
ol ethical na reguletori tok orait bilong WHO kor protokol;
luksave long ol haus sik i insait long kot;
trening bilong ol klinik bilong haus sik long web-bes randomisasen na data sistem;
sipim ol marasin bilong traim olsem ol i askim long olgeta kantri i stap insait .
I kam inap nau, moa long 400 haus sik long 35 kantri i wok long kisim ol sikman na klostu 3500 sikman i bin kisim wok long 17 kantri{4}}
Wanpela intarim trail analisis bai kamap na bai wanpela indipenden grup bilong ol saveman i lukluk long en olsem global Data na Sefti Monitaring Komiti.